Cell Therapy Technologies Market Forecast 2024-2033: Growth Rate, Drivers, And Trends

The Cell Therapy Technologies by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Cell Therapy Technologies Market:

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

According to The Business Research Company’s Cell Therapy Technologies, The cell therapy technologies market size has grown rapidly in recent years. It will grow from $4.29 billion in 2023 to $4.97 billion in 2024 at a compound annual growth rate (CAGR) of 15.8%. The growth in the historic period can be attributed to strong economic growth in emerging markets, increased healthcare expenditure, increased investments by the government in cell-based research, and growing demand for personalized medicine.

The cell therapy technologies market size is expected to see rapid growth in the next few years. It will grow to $8.62 billion in 2028 at a compound annual growth rate (CAGR) of 14.8%. The growth in the forecast period can be attributed to rising aging population, increasing prevalence of cancer, increasing research and development spending in pharmaceutical sector, and advancements in cell therapies. Major trends in the forecast period include developing innovative products, using advanced technologies, development of innovative cell therapies, investing in manufacturing facility, and partnerships and collaborations.

Increasing investments by the government in cell-based research contributed to the growth of the global cell therapy technologies market. Governments are increasingly investing in research activities for developing therapies for diseases such as cancer, cardiovascular disease (CVD), and others. For instance, in May 2022, The California Institute for Regenerative Medicine (CIRM), a research center helping stem cell research invested more than $11 million to fund a clinical trial for a cell therapy for the treatment of throat cancer. The success of this therapy will save patients from undergoing radiotherapy and its side effects.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=4122&type=smp

The cell therapy technologies market covered in this report is segmented –

1) By Product: Consumables, Equipment, Systems And Software

2) By Cell Type: T-Cells, Stem Cells, Other Cells

3) By Process: Cell Processing, Cell Preservation, Distribution And Handling, Process Monitoring And Quality Control

4) By End User: Life Science Companies, Research Institutes And Cell Banks

Major companies operating in the cell therapy technologies market are developing innovative products by using advanced technologies to grow in the market. For instance, in June 2022, Invetech, an Australia-based company that specializes in the design, engineering, and manufacture of commercial-scale diagnostic products and cell and gene therapies launched Korus, a new closed system for autologous cell therapies, to transform the industry standards in elutriation and cell wash. The technology uses a mild elutriation process to supply a cleaner cell population for cell therapy production processes, such as tumor-infiltrated lymphocytes (TIL), dendritic cells, chimeric antigen receptor (CAR)-T cell or induced pluripotent stem cell (IPSC)-derived therapy. It features elutriation and cell wash using gentle counterflow centrifugation and provides purified cell populations for downstream processing development and commercial manufacture. This will help improve the overall performance of processes through higher recovery and purity of target cells. Using the new Korus system, developers can expedite the clinical development and scale-up of their products.

The cell therapy technologies market report table of contents includes: